AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)

Koung Jin Suh(Seoul National University Bundang Hospital), Keun‐Wook Lee(Seoul National University Bundang Hospital)
The Oncologist
April 10, 2023
10.1093/oncolo/oyad059
Cited by 19

Related Papers

EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
|Oncotarget|2017|46
Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer
|Scientific Reports|2021|20
Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With<i>PIK3CA</i>Mutations and Overcoming Strategies
|Anticancer Research|2025|1